U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled, to $3.57 billion, in the third quarter. Meanwhile, ...
Could slightly elevated blood sugar levels lead to serious health problems in the future? A single patient's question sparked ...
Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...
Money Talks News on MSN
The Affordable Wonder Drug That Could Change Cancer Treatment
Trump Warns of Threat to Social Security, Medicare Exclusive: Three-star general pushed out amid tensions with Hegseth GM to ...
In a large real-world Italian cohort, GLP-1 receptor agonist therapy led to measurable rates of type 2 diabetes remission, ...
A gene on the X chromosome revs up inflammation in the female brain, which may explain why rates of multiple sclerosis are ...
This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...
Researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report that an AI-powered lifestyle intervention app for prediabetes reduced the risk of diabetes ...
An experimental GLP-1/glucagon (GCP) dual receptor agonist from Eli Lilly and its Chinese partner Innovent has bested Novo Nordisk’s reigning GLP-1 semaglutide in a phase 3 study across both b | ...
People develop type 2 diabetes for a combination of reasons, like a sedentary lifestyle and an unhealthy diet, but genetics ...
Scientists at Columbia University have discovered that metformin, a common and inexpensive diabetes drug, may help treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback